Gumiguru 2021: Cabozantinib (Cabometyx, Exelixis, Inc.) yakatenderwa neFood and Drug Administration yevakuru nevana varwere vane makore gumi nemaviri zvichikwira avo vane zera repamusoro kana metastatic kusiyanisa thyroi.
Musi waNdira 14, 2019, cabozantinib (CABOMETYX, Exelixis, Inc.) yakabvumidzwa neFood and Drug Administration kune varwere vane hepatocellular carcinoma (HCC) vakamborapwa sorafenib. The appr..
Zvinoenderana neongororo yakaburitswa muNew England Journal of Medicine yakaburitswa munaChikunguru 5, kupona kweCabozantinib kwakazara uye kusaenderera-mberi kune varwere vane advanced hepatocellular carcinoma yaive iri nani kupfuura p ..